Status:

RECRUITING

Austrian Myeloid Registry

Lead Sponsor:

Arbeitsgemeinschaft medikamentoese Tumortherapie

Conditions:

Myeloid Diseases

Eligibility:

All Genders

18+ years

Brief Summary

The Austrian Myeloid Registry (aMYELOIDr) is a non-interventional study. It collects data from patients with the myeloid diseases, primarily myelodysplastic syndromes (MDS), chronic myelomonocytic leu...

Eligibility Criteria

Inclusion

  • Age \>17 years
  • Diagnosis of myeloid disease according to WHO 2016
  • Signed patient informed consent (IC)

Exclusion

  • Patient is unable or unwilling to sign IC

Key Trial Info

Start Date :

July 13 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2030

Estimated Enrollment :

3000 Patients enrolled

Trial Details

Trial ID

NCT04438889

Start Date

July 13 2020

End Date

April 1 2030

Last Update

April 10 2025

Active Locations (16)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (16 locations)

1

LKH Feldkirch, Innere Medizin II, Interne E: Hämatologie und Onkologie

Feldkirch, Austria, 6807

2

KH der Barmherzigen Brüder, Innere Medizin I

Graz, Austria, 8020

3

Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klinische Abteilung für Hämatologie

Graz, Austria, 8036

4

Universitätsklinik Innsbruck, Univ.-Klinik für Innere Medizin V, Hämatologie und Onkologie

Innsbruck, Austria, 6020